BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2824184)

  • 1. Further evidence that gonadal steroids do not modulate brain opiate receptors in male rats.
    Olasmaa M; Limonta P; Maggi R; Dondi D; Martini L; Piva F
    Endocrinol Jpn; 1987 Aug; 34(4):521-9. PubMed ID: 2824184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone does not influence opiate binding sites in the male rat brain.
    Cicero TJ; Newman KS; Meyer ER
    Life Sci; 1983 Sep; 33(13):1231-9. PubMed ID: 6310295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the binding characteristics of hypothalamic mu opioid receptors in rats by gonadal steroids.
    Maggi R; Limonta P; Dondi D; Piva F
    J Steroid Biochem Mol Biol; 1991; 40(1-3):113-21. PubMed ID: 1659872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate receptor characteristics in brains from young, mature and aged mice.
    Ueno E; Liu DD; Ho IK; Hoskins B
    Neurobiol Aging; 1988; 9(3):279-83. PubMed ID: 2840590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3H-dihydromorphine binding sites in subcellular fractions of rat striatum.
    Antkiewicz-Michaluk L; Vetulani J; Havemann U; Kuschinsky K
    Pol J Pharmacol Pharm; 1982; 34(1-3):73-8. PubMed ID: 6300816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL; Recht LD; Pasternak GW
    Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the affinity ligands 14-beta-chloroacetylnaltrexone and 14-beta-bromoacetamidomorphine on [3H]-dihydromorphine binding sites in rat brain.
    Reichman M; Dirksen R; Abood LG; Gala D
    Biochem Pharmacol; 1986 Nov; 35(22):3995-8. PubMed ID: 3022745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of mu-opiate receptors in heroin- and morphine-dependent rats.
    Bolger GT; Skolnick P; Rice KC; Weissman BA
    FEBS Lett; 1988 Jul; 234(1):22-6. PubMed ID: 2839362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding characteristics of mu and kappa agonists in rat brain subcellular fractions.
    Monferini E; Adler MW; Simon EJ
    Life Sci; 1982 Sep 20-27; 31(12-13):1295-8. PubMed ID: 6128655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone and postnatal ontogenesis of hypothalamic mu ([3H]dihydromorphine) opioid receptors in the rat.
    Limonta P; Dondi D; Maggi R; Piva F
    Brain Res Dev Brain Res; 1991 Sep; 62(1):131-6. PubMed ID: 1662120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium-induced alterations of opiate effects on the binding of 3H-dihydromorphine to mouse brain homogenates.
    Chau-Pham TT; King G; Dewey WL
    Life Sci; 1978 Sep; 23(12):1293-9. PubMed ID: 213669
    [No Abstract]   [Full Text] [Related]  

  • 12. Gonadal steroid modulation of brain opioid systems.
    Limonta P; Maggi R; Dondi D; Martini L; Piva F
    J Steroid Biochem; 1987; 27(4-6):691-8. PubMed ID: 2826902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in dihydromorphine binding in cerebral hemispheres of aged male rats.
    Messing RB; Vasquez BJ; Samaniego B; Jensen RA; Martinez JL; McGaugh JL
    J Neurochem; 1981 Feb; 36(2):784-7. PubMed ID: 6257860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T; Zukin RS
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of morphine-epoxide with multiple opiate receptors.
    Konno F; Shibata R; Takayanagi I; Hirobe M
    J Pharmacobiodyn; 1984 Apr; 7(4):221-6. PubMed ID: 6088751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine tolerance is associated with elevated levels of an uncharacterized endorphin (peak B) in mouse brain with no change in 3H-dihydromorphine binding.
    Lipman JJ; Miller BE; Karkara S; Winfield RC; North WC; Byrne WL
    Life Sci; 1983; 33 Suppl 1():373-6. PubMed ID: 6319893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain.
    Brase DA; Han YH; Dewey WL
    Diabetes; 1987 Oct; 36(10):1173-7. PubMed ID: 2820820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific protection of the binding sites of D-Ala2-D-Leu5-enkephalin (delta-receptors) and dihydromorphine (mu-receptors).
    Robson LE; Kosterlitz HW
    Proc R Soc Lond B Biol Sci; 1979 Aug; 205(1160):425-32. PubMed ID: 41257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity of beta-carbolines on rat brain benzodiazepine and opiate binding sites.
    Airaksinen MM; Mikkonen E
    Med Biol; 1980 Dec; 58(6):341-4. PubMed ID: 6112290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid-specific recognition sites of the mu- and the delta-type in rat striatum after lesions with kainic acid.
    Antkiewicz-Michaluk L; Havemann U; Vetulani J; Wellstein A; Kuschinsky K
    Life Sci; 1984 Jul; 35(4):347-55. PubMed ID: 6087059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.